| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |